<DOC>
	<DOCNO>NCT00392743</DOCNO>
	<brief_summary>A direct comparison Positron Emission Tomography ( PET ) ( 11C-Raclopride ) Single Photon Emission Computed Tomography ( SPECT ) ( 123I-IBZM ) D2 RO measurement would allow GSK gain understand SPECT result obtain SB773812 , accurately interpret future D2 RO result either PET SPECT study new compound .</brief_summary>
	<brief_title>A Study Compare Two Different Brain Imaging Techniques Healthy Volunteers Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Inclusion criterion : Not pregnant become pregnant study . No abnormality clinical examination , clinical laboratory test ECG . Not take drug Patients schizophrenia , schizophreniform disorder schizoaffective disorder . Patients least 1 month antipsychotic monotherapy either risperidone , olanzapine clozapine . Healthy volunteer neurological psychiatric illness . Exclusion criterion : Have receive antipsychotic last month neuroleptic last year . If take part investigation receive radiation dose 10 mSv 3 year period . History bleed disorder take medication affect blood clot History substance dependence ( except nicotine ) Claustrophobia Gross head deformity . Unable lie still PET SPECT camera 1 hour half . The presence cardiac pacemaker electronic device ferromagnetic metal foreign body .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Bolus</keyword>
	<keyword>11C-Raclopride</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>123I-IBZM</keyword>
	<keyword>SPECT</keyword>
	<keyword>Receptor Occupancy</keyword>
	<keyword>PET</keyword>
	<keyword>MRI</keyword>
	<keyword>Antipsychotics</keyword>
	<keyword>Bolus/Infusion</keyword>
</DOC>